Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal
- PMID: 37890557
- PMCID: PMC10774583
- DOI: 10.1016/j.ihj.2023.10.007
Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal
Figures


References
-
- Ference B.A., Ginsberg H.N., Graham I., et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–2472. - PMC - PubMed
-
- Esdaile J.M., Abrahamowicz M., Grodzicky T., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 Oct;44(10):2331–2337. - PubMed
-
- Prodanovich S., Kirsner R.S., Kravetz J.D., Ma F., Martinez L., Federman D.G. Association of Psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145(6):700–703. - PubMed
-
- Laurila A., Bloigu A., Näyhä S., Hassi J., Leinonen M., Saikku P. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 1999 Jan;142(1):207–210. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources